Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
TriSalus Life Sciences, Inc. has 4 pending office actions in Medical Devices & Mechanical Engineering. The matters involve 4 distinct examiners and 3 distinct art units, so examiner coverage exceeds art-unit coverage and at least one art-unit setting contains more than one matter.
HUDSON, AMY ROSE is the busiest examiner, with 1 pending matter. Counsel should coordinate device-focused objectives across the portfolio while maintaining separate examiner strategies and tracking matters that share an art-unit context.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUDSON, AMY ROSE | 1 | 74.8% | +11.7% |
| HOUSTON, ELIZABETH | 1 | 37.6% | +42.9% |
| RADOMSKI, MARTIN ADAM | 1 | 33.3% | +45.5% |
| MEDWAY, SCOTT J | 1 | 66.6% | +23.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | HOUSTON, ELIZABETH | — |
| 17970329 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDER HAVING COLLAPSIBLE COVER | RADOMSKI, MARTIN ADAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17236446 | Atraumatic Occlusive System with Compartment for Measurement of Vascular Pressure Change | MEDWAY, SCOTT J | 11d overdue |
| 18285063 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | HUDSON, AMY ROSE | — |
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | HOUSTON, ELIZABETH | — |
| 17970329 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDER HAVING COLLAPSIBLE COVER | RADOMSKI, MARTIN ADAM | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1636 | 1 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18285063 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | HUDSON, AMY ROSE | 1636 | §103DP | Final Rejection | — | Pending | Sep 29, 2023 |
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | HOUSTON, ELIZABETH | 3771 | §102§103§112 | Final Rejection | — | Pending | Nov 22, 2022 |
| 17970329 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED MICROVALVE OCCLUDER HAVING COLLAPSIBLE COVER | RADOMSKI, MARTIN ADAM | 3783 | §102§103 | Final Rejection | — | Pending | Oct 20, 2022 |
| 17236446 | Atraumatic Occlusive System with Compartment for Measurement of Vascular Pressure Change | MEDWAY, SCOTT J | 3783 | §103 | Final Rejection | 11d overdue | Pending | Apr 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTriSalus Life Sciences, Inc. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Amy Rose Hudson has the most, with 1 of TriSalus Life Sciences, Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
